ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2089

The Differential Impact of the Abrogation of the Costimulatory Molecule CD137 Ligand on Renal and Cerebral Manifestations in C57BL/6.Faslpr-/- mice

Anselm Mak1, Bhushan Dharmadhikari2, Lik Wei Wong2, Saji Kumar Sreedharan2 and Herbert Schwarz2, 1Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, 2Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: co-stimulation, Lupus, nervous system lupus and renal disease, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Costimulatory molecules which mediate cross-talks between leukocytes, have been identified to play a pathogenetic pivotal role in systemic lupus erythematosus (SLE). Abrogation of the costimulatory CD137-CD137 ligand (CD137L) system has previously been shown to worsen systemic lupus erythematosus and yet improve experimental autoimmune encephalitis in murine models. Here, we aimed to investigate the phenotypic effects in dermatological, renal and cerebral manifestations, and the potential alterations of the immunological mechanisms when CD137L was absent in a murine lupus model.

Methods: B6.CD137L-/- and lupus-prone C57BL/6.Faslpr-/- (B6.lpr) mice were crossed to obtain mice knocked out for the CD137L and Fas genes (DKO mice). The DKO mice were studied and compared with the B6.lpr mice phenotypically regarding survival, dermatitis, glomerulonephritis, cerebral demyelination, microglial activation and hippocampal long-term potentiation (LTP) induced by theta burst stimulation (TBS). Serological studies and the frequency of splenic leukocyte subsets and helper T (Th) cell transcription factors were studied and compared between the DKO and B6.lpr mice (and B6.WT mice where required).

Results: An observation of 22 months involving 226 DKO and 137 B6.lpr mice demonstrated significantly more severe dermatitis (mean±SE unit: 1.03±0.2 vs. 0.37±0.1, p=0.003), more frequent proliferative glomerulonephritis (33.3% vs. 7.9%, p=0.005) and shorter survival (median± SE survival: 44±4.5 versus 74±3.3 weeks, p<0.001) of the DKO mice compared to the B6.lpr mice. Conversely, microglial activation and cerebral demyelination were milder and the synaptic efficacy in terms of hippocampal LTP was superior in the DKO than B6.lpr mice, without affecting the basal synaptic transmission. DKO mice had a significantly higher frequency of splenic Th17 (CD3+CD4+CD8–RoRγt+) cells than the B6.lpr and B6.WT mice while the frequencies of Th1 and Th2 cells were comparable between the groups. In vitro experiments which involved T-cell stimulation with anti-CD3 did not alter intracellular IL-10 and IL-17 expressions in splenocytes of the DKO and B6.pr mice but a lower proportion of splenic IL-10-producing CD11b+ cells were identified in the DKO mice than in the B6.lpr and B6.WT mice. Serological studies revealed lower serum IL-10 levels in the DKO than in the B6.lpr mice (p=0.017).

Conclusion: In the absence of CD137L, higher splenic Th17 and lower IL-10-producing CD11b+ frequencies and lower serum IL-10 levels may explain the more severe renal and dermatological pathology of B6.lpr mice, yet this creates an environment in the central nervous system for milder cerebral damage and enhanced long-term synaptic plasticity.


Disclosure: A. Mak, None; B. Dharmadhikari, None; L. W. Wong, None; S. K. Sreedharan, None; H. Schwarz, None.

To cite this abstract in AMA style:

Mak A, Dharmadhikari B, Wong LW, Sreedharan SK, Schwarz H. The Differential Impact of the Abrogation of the Costimulatory Molecule CD137 Ligand on Renal and Cerebral Manifestations in C57BL/6.Faslpr-/- mice [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-differential-impact-of-the-abrogation-of-the-costimulatory-molecule-cd137-ligand-on-renal-and-cerebral-manifestations-in-c57bl-6-faslpr-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-differential-impact-of-the-abrogation-of-the-costimulatory-molecule-cd137-ligand-on-renal-and-cerebral-manifestations-in-c57bl-6-faslpr-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology